XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Statements of Operations - USD ($)
12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]    
Product revenue $ 178,146
Cost of product revenue 275,895
Product gross loss (97,749)
Collaborations revenue 64,812 1,926,566
Operating expenses:    
Selling, general and administrative 6,260,266 4,753,036
Research and development 3,925,008 2,075,791
Total operating expenses 10,185,274 6,828,827
Loss from operations (10,218,211) (4,902,261)
Interest expense (3,053) (7,524,581)
Net valuation change of instruments measured at fair value 1,974 804,529
Loss on note extinguishment (2,017,847)
Other income 271,122
Net loss $ (9,948,168) $ (13,640,160)
Net loss per share:    
Basic and diluted (in Dollars per share) $ (0.93) $ (2.52)
Number of shares used in per share calculations:    
Basic and diluted (in Shares) 10,696,799 5,415,424